Paratek Pharmaceuticals, Inc.

PRTK · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$64-$59-$97-$129
Dep. & Amort.$0$0$1-$1
Deferred Tax$0$0$1$0
Stock-Based Comp.$12$14$10$14
Change in WC-$21-$8-$20-$21
Other Non-Cash$5$4$2$3
Operating Cash Flow-$66-$48-$103-$134
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0-$0
Inv. Purchases-$15-$15-$30-$102
Inv. Sales/Matur.$30$20$123$237
Other Inv. Act.$0$0$0$0
Investing Cash Flow$15$5$92$135
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7$18$22$27
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$18$11$58
Financing Cash Flow$5$18$11$58
Forex Effect$0$0$0$0
Net Chg. in Cash-$46-$25$0$58
Supplemental Information
Beg. Cash$81$106$106$48
End Cash$34$81$106$106
Free Cash Flow-$66-$49-$104-$134
Paratek Pharmaceuticals, Inc. (PRTK) Financial Statements & Key Stats | AlphaPilot